Breast cancer echocardiography or ultrasound: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
*Breast ultrasound is not as sensitive as mammography in diagnosing breast cancer. | *Breast ultrasound is not as sensitive as mammography in diagnosing breast cancer. | ||
*It may be used to:<ref name="ss">Breast cancer. Canadian Cancer Society (2015) http://www.cancer.ca/en/cancer-information/cancer-type/breast/signs-and-symptoms/?region=on#ixzz3xScycfqv Accessed on January 16, 2016</ref> | *It may be used to:<ref name="ss">Breast cancer. Canadian Cancer Society (2015) http://www.cancer.ca/en/cancer-information/cancer-type/breast/signs-and-symptoms/?region=on#ixzz3xScycfqv Accessed on January 16, 2016</ref> | ||
*Examine a breast lump or abnormality found during a clinical breast examination or mammogram | :*Examine a breast lump or abnormality found during a clinical breast examination or mammogram | ||
*Determine if a breast lump is a solid tumor or a fluid-filled cyst (sac in the body that is usually filled with fluid or semi-solid material) | :*Determine if a breast lump is a solid tumor or a fluid-filled cyst (sac in the body that is usually filled with fluid or semi-solid material) | ||
*Find an abnormal area for a biopsy | :*Find an abnormal area for a biopsy | ||
:*To evaluate the local extent of breast cancer | |||
:*To identify axillary nodes suspicious for metastasis | |||
*The addition of ultrasound decreases the false negative rate of diagnostic mammography, but we should keep in mind that '''a negative ultrasound and/or mammography does do not exclude the presence of breast cancer'''. | *The addition of ultrasound decreases the false negative rate of diagnostic mammography, but we should keep in mind that '''a negative ultrasound and/or mammography does do not exclude the presence of breast cancer'''. | ||
*US is the first line imaging modality in: | |||
::* Pregnant women | |||
::* Women less than 30 years old with focal breast sign and symptoms | |||
*'''Color Doppler ultrasound:''' | *'''Color Doppler ultrasound:''' | ||
:*May aid in the assessment of breast masses | :*May aid in the assessment of breast masses | ||
Revision as of 14:12, 8 April 2019
|
Breast Cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Breast cancer echocardiography or ultrasound On the Web |
|
American Roentgen Ray Society Images of Breast cancer echocardiography or ultrasound |
|
Risk calculators and risk factors for Breast cancer echocardiography or ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2] Mirdula Sharma, MBBS [3]; Ammu Susheela, M.D. [4]
Overview
Breast ultrasound may be helpful in the diagnosis of breast cancer.
Findings on ultrasound
- Breast ultrasound is not as sensitive as mammography in diagnosing breast cancer.
- It may be used to:[1]
- Examine a breast lump or abnormality found during a clinical breast examination or mammogram
- Determine if a breast lump is a solid tumor or a fluid-filled cyst (sac in the body that is usually filled with fluid or semi-solid material)
- Find an abnormal area for a biopsy
- To evaluate the local extent of breast cancer
- To identify axillary nodes suspicious for metastasis
- The addition of ultrasound decreases the false negative rate of diagnostic mammography, but we should keep in mind that a negative ultrasound and/or mammography does do not exclude the presence of breast cancer.
- US is the first line imaging modality in:
- Pregnant women
- Women less than 30 years old with focal breast sign and symptoms
- Color Doppler ultrasound:
- May aid in the assessment of breast masses
- The absence of flow on Doppler study does not exclude the possibility of malignancy.
Liver Ultrasound
If the blood chemistry tests show increased levels of liver enzymes, a liver ultrasound may be done to check if cancer has spread to the liver (liver metastases). [1]
Herceptin (trastuzumab) induced heart failure
- Trastuzumab is a HER2 receptor blocker, which is used to treat HER2 positive breast cancer.
- It has been shown that heart failure is prevalent in women being treated with this novel treatment.
- According to a small study 58% of women treated with Herceptin for three months, showed pieces of evidence of loss of heart function. (Ref)
- As a potentially serious side effect of this novel treatment serial Echocardiography is recommended in all patients treated with trastuzumab.
References
- ↑ 1.0 1.1 Breast cancer. Canadian Cancer Society (2015) http://www.cancer.ca/en/cancer-information/cancer-type/breast/signs-and-symptoms/?region=on#ixzz3xScycfqv Accessed on January 16, 2016